These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 7828672)
21. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Apodaca G; Rutka JT; Bouhana K; Berens ME; Giblin JR; Rosenblum ML; McKerrow JH; Banda MJ Cancer Res; 1990 Apr; 50(8):2322-9. PubMed ID: 2156617 [TBL] [Abstract][Full Text] [Related]
22. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Alexander JP; Samples JR; Van Buskirk EM; Acott TS Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):172-80. PubMed ID: 1846130 [TBL] [Abstract][Full Text] [Related]
23. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation. Teesalu T; Masson R; Basset P; Blasi F; Talarico D Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151 [TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481 [TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin. Katsuda S; Okada Y; Okada Y; Imai K; Nakanishi I Am J Pathol; 1994 Nov; 145(5):1208-18. PubMed ID: 7977651 [TBL] [Abstract][Full Text] [Related]
27. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. Galis ZS; Sukhova GK; Lark MW; Libby P J Clin Invest; 1994 Dec; 94(6):2493-503. PubMed ID: 7989608 [TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Ueda Y; Imai K; Tsuchiya H; Fujimoto N; Nakanishi I; Katsuda S; Seiki M; Okada Y Am J Pathol; 1996 Feb; 148(2):611-22. PubMed ID: 8579123 [TBL] [Abstract][Full Text] [Related]
29. Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Montgomery AM; De Clerck YA; Langley KE; Reisfeld RA; Mueller BM Cancer Res; 1993 Feb; 53(3):693-700. PubMed ID: 8425205 [TBL] [Abstract][Full Text] [Related]
30. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572 [TBL] [Abstract][Full Text] [Related]
31. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study]. Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371 [TBL] [Abstract][Full Text] [Related]
32. Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Muir D Exp Cell Res; 1994 Feb; 210(2):243-52. PubMed ID: 8299723 [TBL] [Abstract][Full Text] [Related]
33. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses. Syggelos SA; Eleftheriou SC; Giannopoulou E; Panagiotopoulos E; Aletras AJ J Rheumatol; 2001 Jun; 28(6):1319-29. PubMed ID: 11409126 [TBL] [Abstract][Full Text] [Related]
34. TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family. Stetler-Stevenson WG; Krutzsch HC; Liotta LA Matrix Suppl; 1992; 1():299-306. PubMed ID: 1480041 [TBL] [Abstract][Full Text] [Related]
35. Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts. Li L; Akers K; Eisen AZ; Seltzer JL Exp Cell Res; 1997 May; 232(2):322-30. PubMed ID: 9168808 [TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Sugiura Y; Shimada H; Seeger RC; Laug WE; DeClerck YA Cancer Res; 1998 May; 58(10):2209-16. PubMed ID: 9605768 [TBL] [Abstract][Full Text] [Related]
37. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells]. Kikkawa F Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829 [TBL] [Abstract][Full Text] [Related]
38. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: characterization and expression in cultured cells. Winwood PJ; Schuppan D; Iredale JP; Kawser CA; Docherty AJ; Arthur MJ Hepatology; 1995 Jul; 22(1):304-15. PubMed ID: 7601425 [TBL] [Abstract][Full Text] [Related]
39. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix. Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. DeClerck YA; Yean TD; Chan D; Shimada H; Langley KE Cancer Res; 1991 Apr; 51(8):2151-7. PubMed ID: 2009533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]